CoChat

In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions

Open access
Tomar, Dheeraj S., Li, Li, Broulidakis, Matthew P., Luksha, Nicholas G., Burns, Christopher T., Singh, Satish K., Kumar, Sandeep · 2017 · mAbs
Cited by 91

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Early stage developability assessments of monoclonal antibody (mAb) candidates can help reduce risks and costs associated with their product development. Forecasting viscosity of highly concentrated mAb solutions is an important aspect of such developability assessments. Reliable predictions of concentration-dependent viscosity behaviors for mAb solutions in platform formulations can help screen or optimize drug candidates for flexible manufacturing and drug delivery options. Here, we present a computational method to predict concentration-dependent viscosity curves for mAbs solely from their sequence—structural attributes. This method was developed using experimental data on 16 different mAbs whose concentration-dependent viscosity curves were experimentally obtained under standardized conditions. Each concentration-dependent viscosity curve was fitted with a straight line, via logarithmic manipulations, and the values for intercept and slope were obtained. Intercept, which relates to antibody diffusivity, was found to be nearly constant. In contrast, slope, the rate of increase in solution viscosity with solute concentration, varied significantly across different mAbs, demonstrating the importance of intermolecular interactions toward viscosity. Next, several molecular descriptors for electrostatic and hydrophobic properties of the 16 mAbs derived using their full-length homology models were examined for potential correlations with the slope. An equation consisting of hydrophobic surface area of full-length antibody and charges on VH, VL, and hinge regions was found to be capable of predicting the concentration-dependent viscosity curves of the antibody solutions. Availability of this computational tool may facilitate material-free high-throughput screening of antibody candidates during early stages of drug discovery and development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/19420862.2017.1285479

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies

    Brennan, F. R., Morton, L. D., Spindeldreher, S., Kiessling, A., Allenspach, R., Hey, A., Müller, P., Frings, W., & Sims, J. (2010) · mAbs · doi:10.4161/mabs.2.3.11782 · Cited by 250 · cited 1×

    “MAb-based therapeutics can target a wide variety of disease conditions(3) with high target specificity(4) and low non-mechanism toxicity.(5) Often, such products need to be administered at high concentrations to improve patient compliance, ease of administration, and to save on treatment costs.”
    Background

Show all 1 references

Cited by

See all 91

Metadata

Authors
Tomar, D. S., Li, L., Broulidakis, M. P., Luksha, N. G., Burns, C. T., Singh, S. K., & Kumar, S.
Venue
mAbs
Published
2017-01-26
Volume
9
Issue
3
Pages
476-489
ISSN
  • 1942-0862 (ISSN-L)
  • 1942-0870
OpenAlex
W2582317828
Cited by
91
References
1
FWCI
2.81
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions. https://app.cochat.ai/papers/10.1080/19420862.2017.1285479
The paper
Tomar, D. S., Li, L., Broulidakis, M. P., Luksha, N. G., Burns, C. T., Singh, S. K., & Kumar, S. (2017). In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions. mAbs. https://doi.org/10.1080/19420862.2017.1285479

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.